Elpiscience
China - ShanghaiBiotechnology
Focus: Elpiscience is a Shanghai-based biotechnology company focused on developing cancer immunotherapies with oncology-specific expertise. Limited public visibility suggests an emerging or pre-commercial stage player in the competitive immuno-oncology space.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Elpiscience
AI assessmentNot HiringNo open roles listed right now. Follow Elpiscience to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
12 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ES102
Solid TumorsClinical Trials (1)
NCT04730843A Study of ES102 (OX40 Agonist) in Patients With Advanced Solid Tumors
Phase 1Help build intelligence for Elpiscience
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.